TechSci Healthcare Industry Report

Growing prevalence of hypertension is expected to drive the growth of India Losartan market. According to TechSci Research report,  “ India  Losartan Market  By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Others), By Strength (25 mg, 50 mg, 100 mg, Others), By Distribution Channel (Online v/s Offline), By Application (Hypertension, Stroke, Diabetic Nephropathy, Others), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026 ” , the India losartan market is expected to grow at a steady rate during the forecast period. Losartan is an angiotensin II receptor blocker and is available as losartan potassium oral tablets as well as a combination tablet of losartan potassium and hydrochlorothiazide. The consumption of Losartan also delay progression of diabetic nephropathy which is expected to fuel the market growth through FY2026. However, side-effects associated with drug consumption such as dela...

India ornidazole market is expected to grow at a steady rate during the forecast period. The India ornidazole market is driven by the widespread use of the antibiotic in treatment of protozoans infections. Additionally, the extensive use of the drug in the treatment of trichomoniasis is further expected to fuel the market growth through FY2026. Furthermore, the use of drug in treatment of Crohn’s disease after bowel resection is further expected to create lucrative opportunities for the market growth over the next five years. The India ornidazole market is segmented based on composition, source, form, route of administration, distribution channel, application, end user, company and region. Based on source, the market can be split in in-house and contract manufacturing organizations. The contract manufacturing organizations segment is expected to witness significant growth during the forecast period on account of the increasing outsourcing being done by the major pharmaceutical companie...

  Growing prevalence of bacterial infections is expected to drive the growth of India doxycycline market. According to TechSci Research report,  “ India  Doxycycline Market  By Product Type (Doxycycline HCL, Doxycycline Hyclate, Doxycycline Calcium, Doxycycline Monohydrate), By Form (Tablet, Capsule, Injection, Solution, Syrup, Others), By Application (Intestinal Infections, Respiratory Tract Infections, Skin Infections, Genital Infections, Urinary Tract Infections, Others), By Route of Administration (Oral, Intravenous, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By End User , By Company, By Region, Forecast & Opportunities, FY2026 ” , the India doxycycline market is expected to grow at a formidable rate during the forecast period on account of the widespread use of the drug in treatment of acne, cholera, typhus, syphilis, among others. Additionally, doxycycline is present in the WHOs list...